We are live on ! Find out more
SFM

Sphera Funds Management Portfolio holdings

AUM $630M
1-Year Est. Return 108.65%
This Fund
S&P 500
This Quarter Est. Return
+7.08%
1 Year Est. Return
+108.65%
3 Year Est. Return
+217.64%
5 Year Est. Return
+342.91%
10 Year Est. Return
+2,254.45%
AUM
$809M
AUM Growth
+$404M
Cap. Flow
+$13B
Cap. Flow %
1,601.81%
Top 10 Hldgs %
38.43%
Holding
159
New
60
Increased
32
Reduced
34
Closed
31

Top Buys

Rank Stock Value
1
ISRL
Isramco Inc
ISRL
+$12.6B
2
AGN
Allergan plc
AGN
+$27.3M
3
ABBV icon
AbbVie
ABBV
+$22.4M
4
SHPG
Shire pic
SHPG
+$19.6M
5
PFE icon
Pfizer
PFE
+$18.3M

Top Sells

Rank Stock Value
1
SNY icon
Sanofi
SNY
+$12.7M
2
GSK icon
GSK
GSK
+$9.95M
3
BIIB icon
Biogen
BIIB
+$6.94M
4
SGEN
Seagen Inc. Common Stock
SGEN
+$5.6M
5
AVNR
AVANIR PHARMACEUTICALS, INC CL A
AVNR
+$5.12M

Sector Composition

Rank Sector Weight
1 Healthcare 57.07%
2 Technology 4.45%
3 Energy 3.1%
4 Industrials 2.68%
5 Materials 1.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UNP icon
51
Union Pacific
UNP
$174B
$3.5M 0.43%
+32,312
New +$3.35M
ELDN icon
52
Eledon Pharmaceuticals
ELDN
$261M
$3.48M 0.43%
+1,420
New +$4.04M
ICPT
53
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$3.45M 0.43%
+14,565
New +$3.71M
PRQR icon
54
ProQR Therapeutics
PRQR
$243M
$3.44M 0.42%
+200,000
New +$3.2M
AERI
55
DELISTED
Aerie Pharmaceuticals
AERI
$3.38M 0.42%
163,516
+53,516
+49% +$1.06M
CBAY
56
DELISTED
Cymabay Therapeutics
CBAY
$3.35M 0.41%
+490,355
New +$3.01M
CVS icon
57
CVS Health
CVS
$133B
$3.17M 0.39%
39,810
+20,515
+106% +$1.62M
VFC icon
58
VF Corp
VFC
$5.63B
$3.16M 0.39%
+50,870
New +$3.04M
RDUS
59
DELISTED
Radius Health, Inc.
RDUS
$3.15M 0.39%
+150,000
New +$2.03M
SLXP
60
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
$3.13M 0.39%
+20,000
New +$2.9M
XLV icon
61
State Street Health Care Select Sector SPDR ETF
XLV
$41.9B
$3.12M 0.39%
48,853
+19,500
+66% +$1.22M
ARRY
62
DELISTED
Array Biopharma Inc
ARRY
$3.12M 0.39%
873,922
+588,922
+207% +$2.32M
XLRN
63
DELISTED
Acceleron Pharma
XLRN
$3.02M 0.37%
+100,000
New +$2.82M
INCY icon
64
Incyte
INCY
$24.2B
$3M 0.37%
61,173
-11,827
-16% -$593K
AVNR
65
DELISTED
AVANIR PHARMACEUTICALS, INC CL A
AVNR
$2.98M 0.37%
250,000
-750,000
-75% -$5.12M
TJX icon
66
CALL
TJX Companies
TJX
$174B
$2.96M 0.37%
100,000
+99,000
+9,900% +$2.79M
SLB icon
67
SLB Ltd
SLB
$73.6B
$2.93M 0.36%
+28,790
New +$3.14M
YUM icon
68
Yum! Brands
YUM
$41.8B
$2.87M 0.35%
55,515
-22,983
-29% -$1.22M
PTCT icon
69
PTC Therapeutics
PTCT
$5.68B
$2.8M 0.35%
63,625
-86,375
-58% -$2.7M
TW
70
DELISTED
TOWERS WATSON & CO COM STK CL A (DE)
TW
$2.79M 0.34%
28,000
-13,740
-33% -$1.45M
SAGE
71
DELISTED
Sage Therapeutics
SAGE
$2.77M 0.34%
+87,924
New +$2.55M
OTIC
72
DELISTED
Otonomy, Inc.
OTIC
$2.67M 0.33%
+111,085
New +$2.2M
NICE icon
73
Nice
NICE
$5.79B
$2.62M 0.32%
+64,542
New +$2.57M
CL icon
74
Colgate-Palmolive
CL
$73.1B
$2.62M 0.32%
40,099
-7,700
-16% -$508K
IRWD icon
75
Ironwood Pharmaceuticals
IRWD
$696M
$2.52M 0.31%
+231,875
New +$2.65M
1 2
3
4 5

Similar funds

VIM
Vancity Investment Management Vancouver, British Columbia, Canada $629M AUM 2.49% 1-Year Est. Return
KCMH
Keywise Capital Management (HK) Hong Kong $630M AUM 81.01% 1-Year Est. Return
FCFC
First Commonwealth Financial Corp Indiana, Pennsylvania $629M AUM 20.47% 1-Year Est. Return
BI
BlueSpruce Investments Chicago, Illinois $631M AUM 11.83% 1-Year Est. Return
PWW
Pettyjohn Wood & White Lynchburg, Virginia $628M AUM 20.96% 1-Year Est. Return
TTSTC
Texas Treasury Safekeeping Trust Company Austin, Texas $628M AUM 15.58% 1-Year Est. Return
SWP
Summit Wealth Partners Orlando, Florida $632M AUM 9.71% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Sphera Funds Management's Q3 2014 Portfolio in Review

As of Q3 2014, Sphera Funds Management held 159 positions worth $809M, up 99% from $406M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Sphera Funds Management deployed $13B of net new capital in Q3 2014, opening 60 new positions and adding to 32 existing holdings. Its largest new stake was Isramco Inc: 103,111,944 shares worth $22.1M.

By sector, the portfolio is most concentrated in Healthcare at 57% of assets, down from 74% a quarter earlier, followed by Technology and Energy.

On the sell side, the largest reduction was GSK, an estimated $9.95M trimmed.

  • Sphera Funds Management's largest Q3 2014 buy was Isramco Inc: 103,111,944 shares worth $22.1M.
  • Sphera Funds Management added most to Shire pic in Q3 2014, an estimated $19.6M increase.
  • Sphera Funds Management's biggest Q3 2014 reduction was GSK, cutting an estimated $9.95M.
  • Sphera Funds Management fully exited Sanofi in Q3 2014, selling an estimated $12.7M.
  • Sphera Funds Management's ten largest holdings make up 38% of its $809M portfolio in Q3 2014.
  • Sphera Funds Management opened 60 new positions and closed 31 in Q3 2014.
  • Sphera Funds Management's portfolio value rose 99% quarter-over-quarter to $809M.

Based on Sphera Funds Management's 13F filing for Q3 2014, filed 13 Nov 2014.